Propostes de polítiques laborals

Us preocupa el problema de l’atur? Us heu preguntat mai per què Espanya té unes taxes d’atur superiors als països de referència en polítiques laborals? Creieu que el mercat laboral espanyol té moltes mancances? Penseu que el model productiu actual, basat en la construcció i el turisme, és sostenible a llarg termini? Aquestes preguntes, juntament amb la gran destrucció d’ocupació arran de la crisi, -durant l’últim trimestre del 2008 a l’economia espanyola li correspon el 70% (1) de la destrucció de llocs de treball a Europa- ens ha portat a reflexionar sobre els determinants i lesconseqüències de l’atur espanyol. Seguint aquesta línia, ens preguntàvem si,mitjançant un seguit de propostes laborals, Espanya podria arribar a reduir les sevestaxes d’atur a llarg termini i equiparar-les a nivells europeus.Si voleu saber més sobre les possibles solucions, en aquest treball exposemun seguit de mesures originals i d’altres basades en idees d’economistes experts queintenten millorar el capital humà de l’economia, el model productiu, els valors imentalitat de la societat, les institucions laborals i la legislació laboral existent , amb laqual cosa es pretén, com a fi últim, augmentar els nivells d’ocupació de l’economia.Algunes d’aquestes són:· Un nou contracte únic i flexibilització laboral· Canvis en la negociació col·lectiva, fiscalitat empresarial i programes formatius· Model original en les prestacions d’atur· Impuls a un nou model productiuAplicant aquestes propostes creiem que és possible reduir la temporalitat almercat laboral espanyol així com també lluitar per aconseguir la plena ocupaciópromocionant el treball estable i de qualitat. Tot i que el problema de l’atur genera moltdebat social entre els diferents agents socials, les propostes han intentat cercar elconsens i, sobretot, la millora econòmica de la societat.

Antipsychotic polypharmacy in a regional health service: a population-based study

Background To analyse the extent and profile of outpatient regular dispensation of antipsychotics, both in combination and monotherapy, in the Barcelona Health Region (Spain), focusing on the use of clozapine and long-acting injections (LAI). Methods Antipsychotic drugs dispensed for people older than 18 and processed by the Catalan Health Service during 2007 were retrospectively reviewed. First and second generation antipsychotic drugs (FGA and SGA) from the Anatomical Therapeutic Chemical classification (ATC) code N05A (except lithium) were included. A patient selection algorithm was designed to identify prescriptions regularly dispensed. Variables included were age, gender, antipsychotic type, route of administration and number of packages dispensed. Results A total of 117,811 patients were given any antipsychotic, of whom 71,004 regularly received such drugs. Among the latter, 9,855 (13.9%) corresponded to an antipsychotic combination, 47,386 (66.7%) to monotherapy and 13,763 (19.4%) to unspecified combinations. Of the patients given antipsychotics in association, 58% were men. Olanzapine (37.1%) and oral risperidone (36.4%) were the most common dispensations. Analysis of the patients dispensed two antipsychotics (57.8%) revealed 198 different combinations, the most frequent being the association of FGA and SGA (62.0%). Clozapine was dispensed to 2.3% of patients. Of those who were receiving antipsychotics in combination, 6.6% were given clozapine, being clozapine plus amisulpride the most frequent association (22.8%). A total of 3.800 patients (5.4%) were given LAI antipsychotics, and 2.662 of these (70.1%) were in combination. Risperidone was the most widely used LAI. Conclusions The scant evidence available regarding the efficacy of combining different antipsychotics contrasts with the high number and variety of combinations prescribed to outpatients, as well as with the limited use of clozapine. Background To analyse the extent and profile of outpatient regular dispensation of antipsychotics, both in combination and monotherapy, in the Barcelona Health Region (Spain), focusing on the use of clozapine and long-acting injections (LAI). Methods Antipsychotic drugs dispensed for people older than 18 and processed by the Catalan Health Service during 2007 were retrospectively reviewed. First and second generation antipsychotic drugs (FGA and SGA) from the Anatomical Therapeutic Chemical classification (ATC) code N05A (except lithium) were included. A patient selection algorithm was designed to identify prescriptions regularly dispensed. Variables included were age, gender, antipsychotic type, route of administration and number of packages dispensed. Results A total of 117,811 patients were given any antipsychotic, of whom 71,004 regularly received such drugs. Among the latter, 9,855 (13.9%) corresponded to an antipsychotic combination, 47,386 (66.7%) to monotherapy and 13,763 (19.4%) to unspecified combinations. Of the patients given antipsychotics in association, 58% were men. Olanzapine (37.1%) and oral risperidone (36.4%) were the most common dispensations. Analysis of the patients dispensed two antipsychotics (57.8%) revealed 198 different combinations, the most frequent being the association of FGA and SGA (62.0%). Clozapine was dispensed to 2.3% of patients. Of those who were receiving antipsychotics in combination, 6.6% were given clozapine, being clozapine plus amisulpride the most frequent association (22.8%). A total of 3.800 patients (5.4%) were given LAI antipsychotics, and 2.662 of these (70.1%) were in combination. Risperidone was the most widely used LAI. Conclusions The scant evidence available regarding the efficacy of combining different antipsychotics contrasts with the high number and variety of combinations prescribed to outpatients, as well as with the limited use of clozapine.

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

BACKGROUND: Little is known about the long-term changes in the functioning of schizophrenia patients receiving maintenance therapy with olanzapine long-acting injection (LAI), and whether observed changes differ from those seen with oral olanzapine. METHODS: This study describes changes in the levels of functioning among outpatients with schizophrenia treated with olanzapine-LAI compared with oral olanzapine over 2 years. This was a secondary analysis of data from a multicenter, randomized, open-label, 2-year study comparing the long-term treatment effectiveness of monthly olanzapine-LAI (405 mg/4 weeks; n=264) with daily oral olanzapine (10 mg/day; n=260). Levels of functioning were assessed with the Heinrichs-Carpenter Quality of Life Scale. Functional status was also classified as 'good', 'moderate', or 'poor', using a previous data-driven approach. Changes in functional levels were assessed with McNemar's test and comparisons between olanzapine-LAI and oral olanzapine employed the Student's t-test. RESULTS: Over the 2-year study, the patients treated with olanzapine-LAI improved their level of functioning (per Quality of Life total score) from 64.0-70.8 (P<0.001). Patients on oral olanzapine also increased their level of functioning from 62.1-70.1 (P<0.001). At baseline, 19.2% of the olanzapine-LAI-treated patients had a 'good' level of functioning, which increased to 27.5% (P<0.05). The figures for oral olanzapine were 14.2% and 24.5%, respectively (P<0.001). Results did not significantly differ between olanzapine-LAI and oral olanzapine. CONCLUSION: In this 2-year, open-label, randomized study of olanzapine-LAI, outpatients with schizophrenia maintained or improved their favorable baseline level of functioning over time. Results did not significantly differ between olanzapine-LAI and oral olanzapine.

"Gómez Álvarez, Cristina: Navegar con libros. El comercio de libros entre España y Nueva España. Una visión cultural de la Independencia (1750-1820) (2011)". Anuario de Estudios Americanos, v. 70, n. 1 (2013), p. 355-359.

Este libro se ocupa del análisis del tráfico de libros entre Europa y Nueva España durante los años 1750-1820. Se trata de la primera síntesis sobre estos asuntos con la que contamos para este interesante periodo del trasvase cultural entre Europa y México.

Estudio neurofisiológico mediante potenciales evocados auditivos de tronco cerebral y somatosensoriales en pacientes con malformación de Chiari tipo 1.

La malformación de Chiari tipo 1 (MC-1) puede condicionar fenómenos compresivos del tronco del encéfalo, de la médula espinal alta y de los nervios craneales y alterar las exploraciones neurofisiológicas de los potenciales evocados auditivos de tronco cerebral (PEATC) y de los potenciales evocados somatosensoriales (PESS). Este trabajo describe la incidencia y los tipos de hallazgos de los PEATC y PESS en una serie homogénea de 50 pacientes con MC-1 controlados en el Servicio de Neurocirugía del Hospital Universitari Vall d’Hebron y estudia su relación con la sintomatología clínica y la severidad de la malformación.